Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001209191-24-000783

Director sold 13,000 shares at an average $63.76 ($828,915)

  • Director acquired 13,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lukatch Heath Director 2024-01-02 Option exercise 10b5-1 +13,000 $16.00 $208,000 18,625 D
Lukatch Heath Director 2024-01-02 Sale 10b5-1 −1,101 $62.85 $69,201 17,524 D
Lukatch Heath Director 2024-01-02 Sale 10b5-1 −7,444 $63.55 $473,081 10,080 D
Lukatch Heath Director 2024-01-02 Sale 10b5-1 −4,164 $64.28 $267,662 5,916 D
Lukatch Heath Director 2024-01-02 Sale 10b5-1 −291 $65.19 $18,971 5,625 D
Derivatives
Lukatch Heath Director 2024-01-02 Option exercise · Stock Option (right to buy) 10b5-1 −13,000 15,000 D
Open-market sales · 13,000 sh · avg $63.76 · $828,915
Loading xslF345X05/doc4.xml…